Overview

Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents

Status:
Unknown status

Trial end date:
0000-00-00

Target enrollment:

Participant gender:

Summary

To evaluate the performance and safety of seven T.R.U.E. Test Panel allergens in subjects 6-17 years of age with suspected contact dermatitis.

Phase:

Phase 4

Details

Lead Sponsor:

Allerderm

Treatments:

Bacitracin
Bronopol
Cortisol succinate
Gold Sodium Thiosulfate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Hydrocortisone-17-butyrate
Parthenolide
Sodium thiosulfate